Anzeige
Mehr »
Login
Donnerstag, 02.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
"Special Situation"-Aktie mit Multi-Tenbagger-Potenzial im heißesten Rohstoff-Markt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
59 Leser
Artikel bewerten:
(0)

Research and Markets - $3.2 Billion Neurorehabilitation Devices Market 2016-2024: Key Players are Bioness, Inc., Ectron Ltd., Hocoma AG, Medtronic, and Tyromotion

DUBLIN, November 2, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Neurorehabilitation Devices Market By Products, By Therapy Area And Segment Forecasts To 2024" report to their offering.

The global neurorehabilitation devices market in 2015 was valued at USD 915.1 million and is estimated to reach USD 3.2 billion by 2024

The increasing prevalence and incidence rates of neurological disorders create a huge demand for neurorehab devices, as they ensure simplification of routine tasks for the disabled patients by reducing their dependency on others.

Furthermore, the rising awareness of neurorehab services among the care providers is contributing to the increasing adoption of these devices. In addition, consistent technological advancements are leading to introduction and commercialization of novel products in this sector.

Majority of the manufacturers and distributors of neurorehab platforms are headquartered in North America region. North America dominates the market followed by Europe attributed to the rising awareness and increased adoption of novel technologies in these regions. Asia Pacific is growing at the highest CAGR among all the regions due to increasing target population and improving healthcare infrastructure.

Despite fluctuating economic conditions across different geographical regions coupled with the respective regulatory pressures, the companies offering neurorehab devices and services are exhibiting adaptability and efficacy.

Some of the key market players are Bioness, Inc., Ectron Ltd., Hocoma AG, Medtronic, and Tyromotion. Collaborations for novel product development and strengthening of distribution networks constitute some of the strategic initiatives implemented by key players.

For instance, Ectron Ltd. has collaborated with Bioness, Inc. and Tyromotion for distribution of their products across different geographical regions.

Key Topics Covered:

1 Research Methodology & Scope

2 Executive Summary

3 Market Snapshot

4 Market Variables, Trends & Scope

5 Market Categorization 1: Product Estimates & Trend Analysis

6 Market Categorization 2: Therapy Area Estimates & Trend Analysis

7 Market Categorization 3: Regional Estimates & Trend Analysis, by Product & Therapy Areas

Company Profiles

  • Biometrics Ltd
  • Bioness, Inc.
  • Bionik Laboratories Corp. (BNKL)
  • Bioxtreme Robotics Rehabilitation
  • Ectron Ltd
  • Ekso Bionics
  • Hocoma AG
  • Kinestica
  • Kinova Robotics
  • Medtronic PLC
  • NINET
  • Saebo Ltd
  • St. Jude Medical
  • Tyromotion

For more information about this report visit http://www.researchandmarkets.com/research/xrj2nd/neurorehabilitatio

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.